Ignite Creation Date:
2024-05-05 @ 11:24 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01328392
Status:
WITHDRAWN
Last Update Posted:
2017-07-05
First Post:
2011-03-30
Brief Title:
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux
Status:
WITHDRAWN
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The sponsor did not fund the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Although laryno-pharyngeal reflux LPR and gastroesophageal reflux disease GERD differ in symptoms and treatment they are diagnosed by the same standard 24-hour pH monitoring system which measures liquid reflux in the esophagus The investigators are evaluating a new 24-hour pharyngeal pH monitoring system by Restech which can measure acid exposure in the airway and can be used specifically for LPR diagnosis The purpose of this study is to determine whether the Restech device is more effective than standard pH monitoring in predicting the response to proton pump inhibitor PPI acid suppression therapy using Dexlansoprazole in patients with symptoms andor manifestations of LPR
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None